Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report

C Kearon, EA Akl, J Ornelas, A Blaivas, D Jimenez… - Chest, 2016 - Elsevier
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …

C Kearon, EA Akl, AJ Comerota, P Prandoni… - Chest, 2012 - Elsevier
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …

Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines

C Kearon, SR Kahn, G Agnelli, S Goldhaber… - Chest, 2008 - Elsevier
This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

HR Büller, G Agnelli, RD Hull, TM Hyers, MH Prins… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy for venous thromboembolic disease is part of the
seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Treatment of venous thromboembolism

PS Wells, MA Forgie, MA Rodger - Jama, 2014 - jamanetwork.com
Importance Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a common, potentially lethal condition with acute morbidity …

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …

[HTML][HTML] Venous thromboembolism: Recent advancement and future perspective

Y Yamashita, T Morimoto, T Kimura - Journal of Cardiology, 2022 - Elsevier
Clinicians have been more and more often encountering patients with venous
thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis, leading …

Direct oral anticoagulants in patients with VTE and cancer

MC Vedovati, F Germini, G Agnelli, C Becattini - Chest, 2015 - Elsevier
BACKGROUND Direct oral anticoagulants (DOAs) have been shown to be as effective and
at least as safe as conventional anticoagulation for the prevention of recurrences in patients …